Latest news
Primer: GC Biopharma Corp (006280 KS) - Aug 2026 - SmartkarmaSmartkarma · Fri, 07 Aug 2026 05:27:29 GMTGC Biopharma Maps mRNA-LNP Degradation - BusinesskoreaBusinesskorea · Fri, 07 Aug 2026 02:47:37 GMTGC Biopharma Q2 Profit Slumps on Deferred Sales, Recovery Seen in H2 - Seoul Economic DailySeoul Economic Daily · Mon, 03 Aug 2026 23:54:18 GMT006280 Stock Price and Chart — KRX:006280 - TradingViewTradingView · Fri, 31 Jul 2026 07:00:00 GMTGC Biopharma Q2 Operating Profit Plunges 94%; Eyes Rebound in H2 on Flu Vaccine, Alyglo - finance.biggo.comfinance.biggo.com · Fri, 31 Jul 2026 07:00:00 GMTGC Biopharma profits plunge in Q2, forecast rebounds in Korea H2 sales - CHOSUNBIZ - ChosunbizChosunbiz · Fri, 31 Jul 2026 07:00:00 GMTGc Biopharma Q2 Operating. Profit 1.7 Billion Won, Down 93.8% Y/Y - TradingViewTradingView · Fri, 31 Jul 2026 06:45:00 GMTGC Biopharma Files for Phase 2 Trial of COVID-19 mRNA Vaccine, Targets 2028 Approval - Seoul Economic DailySeoul Economic Daily · Mon, 27 Jul 2026 07:00:00 GMT